Antibiotics may help treat common form of dementia: Study
Team Udayavani, Jan 11, 2020, 4:16 PM IST
Washington: Researchers have found that a class of antibiotics called ‘aminoglycosides’ may be a promising treatment for a form of early onset dementia, an advance that may lead to new clinical strategies against the memory decline syndrome.
According to the study, published in the journal Human Molecular Genetics, frontotemporal dementia, the most common type of the syndrome, begins between ages 40 and 65, and affects the frontal and temporal lobes of the brain.
Some patients with this form of dementia have a specific genetic mutation which prevents their brain’s cells from making a protein called progranulin, the scientists said in a statement.
While the protein is not thoroughly studied, researchers believe that its absence is linked to this form of dementia.
In the current study, scientists discovered that after aminoglycoside antibiotics were added to nerve cells exhibiting this mutation, the cells started making full-length progranulin protein by skipping the mutation.
“These patients’ brain cells have a mutation that prevents progranulin from being made. The team found that by adding a small antibiotic molecule to the cells, they could ‘trick’ the cellular machinery into making it,” said Matthew Gentry, a co-author of the study from the University of Kentucky.
Two aminoglycoside antibiotics – Gentamicin and G418 – were both effective in fixing the mutation, and making the functional progranulin protein, the study noted.
According to the researchers, adding Gentamicin or G418 molecules to the affected cells, caused them to produce the protein at levels of up to 50 to 60 per cent as produced by normal cells without the mutation.
The scientists plan to study the antibiotics’ effects on mice carrying the mutation which causes frontotemporal dementia.
While Gentamicin is a clinically approved medicine, the researchers said its usage is limited since it is associated with a number of adverse side effects.
“If we can get the right resources and physician to work with, we could potentially repurpose this drug. This is an early stage of the study, but it provides an important proof of concept that these aminoglycoside antibiotics or their derivatives can be a therapeutic avenue for frontotemporal dementia,” said study co-author Haining Zhu from the University of Kentucky.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
50-60% cancer cases detected in India annually are preventable, say oncologists
Doctors report treating ‘petticoat cancer’ in women who might have tied sarees tightly at waist
The Role of Screening and Early Detection in Liver Cancer
Need to recognise obesity as chronic disease: Experts
Study reveals how gut microbes work with body clock in managing stress
MUST WATCH
Latest Additions
BCCI vs PCB spar on CT venue as Naqvi denies receiving any official note from Indian board
Use Carnatic music to promote Kannada language: Nirmala Sitharaman
Udupi: Car collides with bike; Rider injured
UP women’s body proposes men shouldn’t tailor women’s clothes or cut their hair
NSE, BSE to be closed on Nov 20 for Maharashtra assembly polls
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.